24 Followers on Owler
Cognition is a New York-based biopharmaceutical company that researches and develops small-molecule therapeutics for the treatment of neurodegenerative diseases... Read more
OverviewCompetitorsFundingInvestmentsNews & Insights
Cognition is a New York-based biopharmaceutical company that researches and develops small-molecule therapeutics for the treatment of neurodegenerative diseases... Read more
Cognition Therapeutics President & CEO: Lisa Ricciardi

President & CEO

Lisa Ricciardi

CEO Approval Rating

85/100

2007

PublicNASDAQCGTX

Pharmaceuticals & Biotechnology
Biotechnology
28362834 NAICS listing

Annual Revenue
<$1M
Employees
20
Funding
$299.5M
Investments
1

News

Conference Presentation
Dec 01, 2025
StreetInsider
Cognition Therapeutics Presents Phase 3 Plan for Zervimesine (CT1812) in Alzheimer's Disease at Clinical Trials on Alzheimer's Disease (CTAD) Conference
Funding
Sep 03, 2025
GlobalNewswire
Cognition received $30M in Post-IPO Equity Funding

Cognition Therapeutics Competitors

1Alector
2ProMIS Neurosciences
3Verge Genomics
4Alzheon
5Voyager
6Omeros
7Auspex Pharmaceuticals
8Minerva Neurosciences
9Oncimmune
Unlock 6 + competitors

Trending Companies